SimAbs NV will be exhibiting at BIO International Convention 2026, taking place June 22–25 at the San Diego Convention Center in San Diego, California. (https://convention.bio.org/)
We are joining as part of the Flanders Investment & Trade pavilion at booth 4623.
Anton and Ajay will be present throughout the event and available to meet…
Press Release
simAbs and Ardent Biopharma Announce Exclusive Strategic Partnership to Advance Next-Generation Biosimilar Manufacturing
Hasselt, Belgium & Leiden, The Netherlands – April 7th, 2026
simAbs NV and Ardent Biopharma BV today announced an exclusive strategic development partnership focused on the development of two monoclonal antibody biosimilars, AB01 and AB02, using next-generation continuous manufacturing technologies…
SimAbs Raises €5 Million Series A to Scale Continuous GMP Manufacturing and expand current development for Antibodies and Biosimilars: Cells in, Drug Substance out.
Diepenbeek, BioVille, Belgium, December 18, 2025 – SimAbs is proud to announce the successful closing of a €5 million Series A financing round. This investment marks a major step in the…